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Abstract
The cysteine-rich somatomedin B domain (SMB) of the matrix protein vitronectin is involved in several
important biological processes. First, it stabilizes the active conformation of the plasminogen activator
inhibitor (PAI-1); second, it provides the recognition motif for cell adhesion via the cognate integrins (avb3,
avb5, and aIIbb3); and third, it binds the complex between urokinase-type plasminogen activator (uPA) and
its glycolipid-anchored receptor (uPAR). Previous structural studies on SMB have used recombinant protein
expressed in Escherichia coli or SMB released from plasma-derived vitronectin by CNBr cleavage.
However, different disulfide patterns and three-dimensional structures for SMB were reported. In the present
study, we have expressed recombinant human SMB by two different eukaryotic expression systems, Pichia
pastoris and Drosophila melanogaster S2-cells, both yielding structurally and functionally homogeneous
protein preparations. Importantly, the entire population of our purified, recombinant SMB has a solvent
exposure, both as a free domain and in complex with PAI-1, which is indistinguishable from that of plasma-
derived SMB as assessed by amide hydrogen (1H/2H) exchange. This solvent exposure was only reproduced
by one of three synthetic SMB products with predefined disulfide connectivities corresponding to those
published previously. Furthermore, this connectivity was also the only one to yield a folded and functional
domain. The NMR structure was determined for free SMB produced by Pichia and is largely consistent with
that solved by X-ray crystallography for SMB in complex with PAI-1.
Keywords: vitronectin; PAI-1; NMR; amide hydrogen (1H/2H) exchange; mass spectrometry; disulfide-
knot; somatomedin B domain; protein structure
Vitronectin is an abundant glycoprotein primarily found
circulating in blood (400 mg/L or 5 mM), where it is
believed to be involved in regulation of hemostasis and
vascular remodeling. Comparative studies using vitro-
nectin-deficient mice highlight a role of vitronectin in
stabilizing formed thrombi. Genetic ablation of vitro-
nectin consequently leads to an increased frequency of
embolization due to the instability of the generated
thrombi (Reheman et al. 2005). Elevated concentrations
of plasma vitronectin correlate to the severity of coronary
atherosclerosis (Ekmekci et al. 2002). A matrix-deposited
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talet section 3735, Copenhagen Biocenter Room 3.3.31, Ole Maaløes
Vej 5, DK-2200 Copenhagen N, Denmark; e-mail: m-ploug@finsenlab.
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Abbreviations: HSQC, heteronuclear single quantum coherence;
MALDI-TOF MS, matrix assisted laser desorption ionization time-
of-flight mass spectrometry; NMR, nuclear magnetic resonance; NOE,
nuclear Overhauser effect; PAI-1, plasminogen activator inhibitor-1;
RMSD, root mean square deviation; SMB, somatomedin B; uPA,
urokinase-type plasminogen activator; uPAR, urokinase-type plasmin-
ogen activator receptor.
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form of vitronectin plays a role in integrin-mediated
cellular adhesion and migration through its RGD-motif
(residues 45–47). Furthermore, vitronectin is required for
urokinase-type plasminogen activator receptor (uPAR)-
dependent activation of the Rac-mediated signaling
pathway leading to increased cell motility (Kjøller and
Hall 2001).
Vitronectin is composed of several functional domains,
which bind a plethora of ligands. Its hemopexin-like
domains are, for example, reported to bind plasminogen,
urokinase-type plasminogen activator (uPA), terminal com-
plement components, collagen, and heparin (Preissner
and Seiffert 1998). Of particular interest is the cysteine-
rich, N-terminal somatomedin B (SMB) domain, which
contains the binding determinants for the plasminogen
activator inhibitor-1 (PAI-1) (Seiffert and Loskutoff
1991; Deng et al. 1996b), the urokinase-type plasminogen
activator receptor (uPAR) (Wei et al. 1994; Deng et al.
1996a; Gårdsvoll and Ploug 2007), and the integrins
avb3, avb5, and aIIbb3 (Cheresh et al. 1989; Wayner
et al. 1991).
The interaction of this small SMB domain with PAI-1
stabilizes the serpin in its active form by attenuating the
latency transition to the inactive form (Seiffert et al.
1994). The RGD sequence found adjacent to the SMB
domain binds to several members of the integrin family
(avb3, avb5, and aIIbb3), which causes integrin-express-
ing cells to adhere to and migrate on vitronectin sub-
strates (Cheresh et al. 1989; Wayner et al. 1991). The
RGD-motif is inaccessible in plasma vitronectin, sug-
gesting that vitronectin exists in multiple conforma-
tions (Seiffert and Smith 1997). The SMB domain also
binds the glycolipid-anchored uPAR (Deng et al. 1996a;
Gårdsvoll and Ploug 2007). This interaction promotes
integrin-independent cell adhesion in a process that is
facilitated by receptor occupancy by the primary ligand,
the serine protease uPA (Wei et al. 1994). The binding sites
for PAI-1 and uPAR on the SMB domain are overlapping,
and these ligands compete mutually for this binding site
(Deng et al. 1996a). Binding of PAI-1 to vitronectin also
competes with integrin binding to the RGD-motif, causing
detachment of cells from the vitronectin matrix (Stefanson
and Lawrence 1996). Cell adhesion and migration are
important processes for normal tissue remodeling as typi-
fied by wound healing and for pathological conditions such
as cancer invasion and metastasis.
No experimental high-resolution structure of intact
vitronectin has been presented so far, but studies on
monomeric, plasma-derived vitronectin by small-angle
X-ray scattering reveal a roughly peanut-shaped molecule
with a maximum length of 110 Å (Lynn et al. 2005). In
contrast, several structures have been reported for its
cysteine-rich SMB domain (Zhou et al. 2003; Kamikubo
et al. 2004; Mayasundari et al. 2004). Nonetheless,
considerable controversy exists in the literature regarding
the disulfide connectivity of this domain. Three different
disulfide connectivities (Fig. 1) have thus been assigned
by either X-ray crystallography (Zhou et al. 2003) or by
biochemical methods (Kamikubo et al. 2002; Horn et al.
2004). The SMB preparations used were produced either
recombinantly in Escherichia coli (Kamikubo et al. 2002;
Zhou et al. 2003) or derived from plasma vitronectin
by CNBr cleavage (Horn et al. 2004). Adding to this
controversy, different three-dimensional structures have
been solved for these preparations. Several explanations
have been put forward to explain these inconsistencies. It
has been proposed that bacterial expression and refolding
introduce erroneous disulfide bridges (Horn et al. 2004),
that multiple different disulfide connectivities can yield
biologically active SMB (Kamikubo et al. 2004; Cheek
et al. 2006), that the plasma-derived SMB represents a
biologically inactive form (Kamikubo et al. 2006), or that
significant thiol–disulfide interchange has occurred dur-
ing biochemical assignment of the disulfide arrangements
(Li et al. 2007).
To circumvent the possible pitfalls of recombinant
expression in prokaryotes, we have in the present study
chosen to express the SMB domain in two different
eukaryotic expression systems: Pichia pastoris and S2-
cells from Drosophila melanogaster. To verify that our
recombinant products are similar to plasma-derived SMB,
we made a direct comparison of the global amide hydro-
gen (1H/2H) exchange kinetics of these domains, and
investigated their functional status by comparing the
protection conferred by binding to PAI-1. Both recombi-
nant products were shown to behave similarly to plasma
SMB. The recombinant SMB produced in P. pastoris
was used for three-dimensional structure determination
by nuclear magnetic resonance (NMR) spectroscopy
Figure 1. Disulfide connectivities reported for the SMB domain of human
vitronectin. Three different disulfide connectivities have been assigned
experimentally for the SMB domain—SMB-1: connectivity determined
biochemically after partial reduction of refolded SMB produced in E. coli
(Kamikubo et al. 2002); SMB-2: connectivity determined by X-ray
crystallography of refolded SMB produced in E. coli (Zhou et al. 2003);
and SMB-3: connectivity determined biochemically after partial reduction
of SMB derived from plasma vitronectin by CNBr cleavage (Horn et al.
2004).
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utilizing the possibility for stable isotope labeling offered
by this expression host.
Results
Expression and labeling of SMB produced in P. pastoris
In this study, we chose to express the SMB domain of
vitronectin in two different eukaryotic expression systems
(P. pastoris and D. melanogaster S2 cells). This strategy
is expected to minimize the potential risk of generating an
ensemble of misfolded proteins with nonnative disulfide
pairing similar to that reported previously for the expres-
sion of recombinant SMB in E. coli, which yielded only
;10% binding-active SMB (Kamikubo et al. 2002).
It is well established that Pichia is able to produce high
amounts of disulfide-rich proteins that often fail to
express properly in E. coli (White et al. 1994). Further-
more, Pichia can grow on minimal medium, thus enabling
stable isotope labeling for NMR studies (Laroche et al.
1994). The vector for expression in Pichia was con-
structed to ensure that the protein retained its native N
terminus as only one Kex2 site was maintained for cleav-
age of the a-factor signal (see Materials and Methods),
and the vector also contained a C-terminal histidine tag
for purification. Expression of SMB (residues 1–47) in la-
beled minimal medium yields 3–4 mg of purified SMB/L
medium with a purity of >95% as assessed by SDS-PAGE
and MALDI-TOF MS (data not shown).
With a view to the existing controversy in the literature
regarding the structure and disulfide configurations of the
SMB domain, it is extremely important to ensure that our
recombinant SMB domains are identical to the physio-
logically relevant SMB domain. Thus for comparison, we
also used S2 cells from D. melanogaster as an expression
host for the production of recombinant SMB (Gårdsvoll
et al. 2007), utilizing the full protein-processing ma-
chinery of a higher eukaryote to ensure proper folding.
Accordingly, we have previously used S2 cells to express
highly disulfide-bonded proteins in their active, native
conformation (Gårdsvoll et al. 2004, 2006, 2007), and
importantly, the two possible N-linked glycosylation sites
of the chosen purification tag (i.e., uPAR domain III)
provide a retention signal for the small non-glycosylated
SMB domain, enabling its processing by the calrecticulin/
calnexin complex and the associated protein-disulfide
isomerase (Molinari 2007).
Comparison of recombinant SMB with SMBplasma derived
from purified native vitronectin
To determine if our recombinant SMB domains produced
in the two different eukaryotic hosts have the same
overall structure as native SMBplasma that was derived
from purified plasma vitronectin by CNBr cleavage, we
compared their global amide hydrogen (1H/2H) exchange
kinetics, to assess their overall solvent exposure. Secon-
dary and tertiary structural elements in proteins render
some amides inaccessible for interaction with the sur-
rounding solvent, which is revealed as slowly exchanging
amides in isotope exchange experiments. The hydrogen
exchange profile of a given protein thus constitutes a
sensitive and powerful tool to uncover subtle changes in
solvent exposure or stability among various protein pre-
parations. Hydrogen (1H/2H) exchange kinetics is sensi-
tive to differences in both structure and dynamics of the
molecules and probes the structure of any subpopulation
in the entire protein preparation.
The three different preparations of SMB used in this
study have different molecular masses and can therefore be
resolved in a single mass spectrum (Fig. 2, upper panel).
This facilitates a direct comparison and greatly improves the
data quality, because it allows the hydrogen exchange to be
performed simultaneously for a mixture of the three SMB
preparations. Importantly, this experimental setup enables a
meticulous comparison of the global exchange kinetics for
all three SMB variants, as they encounter exactly identical
exchange times during sampling as well as back-exchange
during desalting. The progress of the hydrogen exchange is
revealed by a gradual shift in the mass envelope for SMB
domains (Fig. 2, lower left panel). These mass envelopes are
subsequently processed to calculate the average number
of unexchanged amides remaining in the respective SMB
preparation as a function of exchange time. This serves to
eliminate the differences in the number of incorporated
deuterons caused by varying chain lengths of the presumed
unstructured C-termini and allows a direct comparison of
the number of protected amides in the three different SMB
variants. Such thorough examinations reveal indistinguish-
able exchange kinetics, implicating the same number of
protected amides for all three variants of SMB (Fig. 2, lower
right panel). This clearly indicates that they have compara-
ble overall structures and conformational stability within the
timescale addressed by the isotope exchange experiment.
To verify that the exchange kinetics is, indeed, a sensitive
probe of structural perturbations, we furthermore tested a
single-site mutant of SMBD22R. As shown in Figure 2
(lower right panel), there is a dramatic increase in the
rate of isotopic exchange in SMBD22R compared to the wild-
type SMB preparations, which highlights the sensitivity of
amide hydrogen (1H/2H) exchange to probe structural
perturbations.
Functional status of recombinant and native SMB
The differences between the three-dimensional structures
reported for SMB could possibly be explained if only one
Kjaergaard et al.
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of the forms retained biological activity and the other
represented a stable but misfolded state without bio-
logical activity. Both SMB variants produced in E. coli
bind PAI-1, which demonstrates that they have a bio-
logically active conformation (Kamikubo et al. 2002;
Zhou et al. 2003). This led to the proposition that the
native SMB domain derived from purified plasma vitro-
nectin used by Peterson and coworkers is not biologi-
cally active (Kamikubo et al. 2006). As a consequence,
we tested the functional status of our recombinant SMB
and plasma-derived SMB by comparing the hydrogen
(1H/2H) exchange profile for these SMB preparations in
the presence and absence of the cognate high-affinity
ligand PAI-1. As shown in Figure 3 (lower panel), the
complex formation between PAI-1 and SMB caused a
dramatic retardation in the exchange rates for approx-
imately nine amides in all three SMB domains compared
in this study. The slow dissociation of the SMBPAI-1
complex and the stability of its corresponding binding
interface is illustrated by the longevity of the protection
observed for amide hydrogens in the complex, where an
average of more than five amide hydrogen atoms were
retained in the complex after 50 min of isotope ex-
change at 25°C (Fig. 3, lower panel). The three SMB pre-
parations tested were thus still indistinguishable when
the exchange was performed in the presence of PAI-1.
This finding further substantiates that both our recombi-
nant SMB domains are structurally and functionally
identical to the plasma-derived SMB. In conclusion, we
find that both the plasma-derived and our recombinant
forms of SMB are in a stable and biologically active
conformation.
Importantly, this hydrogen (1H/2H) exchange experi-
ment also revealed structural and functional homogeneity
of the entire population of our His-tag purified SMB
produced in Pichia. The isotope mass distributions in all
of our exchange experiments move as single envelopes
(Figs. 2 and 3), which unambiguously demonstrates that
our SMB preparations are 100% homogeneous with
respect to their global stability as well as their PAI-1-
binding properties. This is in sharp contrast to expression
in E. coli, where only ;10% of the His-tag purified
recombinant SMB was reported to be biologically active
(Kamikubo et al. 2002).
Figure 2. Comparison of global hydrogen (1H/2H) exchange properties of different preparations of SMB. (Upper panel) A full scan
mass spectrum of the quadruple charge state of the three forms of the SMB domain that we tested simultaneously in this study. The
monoisotopic masses are shown, which translate into the following neutral molecular masses—SMBS2: 5588.33 Da (Dm ¼ 0.17 Da);
SMBplasma: 5758.51 Da (Dm ¼ 0.18 Da); and SMBPichia: 6150.67 Da (Dm ¼ 0.21 Da). Deviations from the theoretical masses are
shown in brackets. SMBplasma contains an additional molecular species (5776.50 Da) due to an incomplete conversion between
homoserine and homoserine lactone after CNBr cleavage. (Lower left panel) The mass spectra obtained for SMBplasma and SMBPichia
are shown as a function of exchange time after dilution into deuterium oxide at 25°C. Notably, only one isotope envelope is produced
by this exchange experiment for each SMB variant. (Lower right panel) The residual 1H content as a function of exchange time is
illustrated for the three different wild-type SMB preparations, as well as a single-site mutant (SMBD22R) with impaired binding to
PAI-1 and uPAR.
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Impact of disulfide connectivity on stability
and function of SMB
To explore the possible disulfide connectivity of our
recombinant SMBPichia, we compared its solvent exposure
to those of three synthetic SMB polypeptides with prede-
fined disulfide bonding as in SMB-1, SMB-2, and SMB-3
(Fig. 1) by hydrogen (1H/2H) exchange. These SMB pre-
parations were synthesized chemically using native chem-
ical ligation and orthogonal cysteine protection (Li et al.
2007). As shown in Figure 4 (upper panel), only one of the
three synthetic SMB samples tested exhibited a solvent
exposure comparable to the one recorded for SMBPichia.
This suggests that only the disulfide connectivity found in
SMB-2 provides a domain structure and stability similar
to that for SMBPichia. Before the first data points were
recorded, both synthetic SMB-1 and SMB-3 exchanged
completely, as expected for misfolded polypeptides.
In separate experiments, where hydrogen (1H/2H)
exchange was performed in the presence of a molar
excess of PAI-1 (Fig. 4, lower panel) only the synthetic
product representing SMB-2 obtained a protection com-
parable to that observed for SMBPichia. Under these
conditions, neither SMB-1 nor SMB-3 experienced any
protection from PAI-1, excluding the formation of stable
SMBPAI-1 complexes consistent with data recorded by
surface plasmon resonance as published by Li et al. (2007).
NMR structure determination
The recombinant SMB produced in P. pastoris is ideally
suited for structure determination by NMR, as this
Figure 3. PAI-1 induces similar protection of amide hydrogens in
recombinant and plasma-derived SMB as monitored by global hydrogen
(1H/2H) exchange. The global exchange profiles recorded by mass
spectrometry for SMBPichia alone (upper left panel) and in complex with
PAI-1 (upper right panel) are shown as time-course experiments. In the
SMBPAI-1 complex experiment, 7 mM SMB was preincubated with
60 mM PAI-1 before the exchange was initiated by a 25-fold dilution
in deuterium oxide. (Lower panel) A summary of the calculated residual
1H content in SMBPichia, SMBS2, and SMBplasma as a function of exchange
time and occupancy with PAI-1.
Figure 4. Comparison of synthetic SMB domains with predefined
disulfide connectivities and SMBPichia reveals different global hydrogen
(1H/2H) exchange kinetics. The solvent exposure of three different
synthetic SMB domains with predefined disulfide connectivities (Fig. 1)
was compared pairwise with that of SMBPichia as outlined in Figure 2.
(Upper panel) The global exchange profiles of the free SMB domains
reveal that only SMB-2 resembles SMBPichia in this respect. Both SMB-1
and SMB-3 are fully exchanged before the first data point. (Lower panel)
The functional integrity of these SMB domains are probed by PAI-1-
induced changes in their global hydrogen exchange profiles. Only SMB-2
and SMBPichia bind PAI-1 as assessed by their reduced solvent exposure.
Kjaergaard et al.
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expression host offers the possibility for stable isotope
labeling, high yields, and a product that retains the overall
folding and functional properties of the SMBplasma
derived from plasma-purified vitronectin.
An examination of various solution conditions using
HSQC spectra of 15N-labeled SMB (120 mM) showed that
at pH 7.4, three peaks are missing compared to pH 6.5,
presumably due to fast exchange with the solvent. The
presence of 50 mM NaCl and 20 mM phosphate buffer
did not affect the spectrum, compared to water alone. For
the subsequent structure determination, we thus used a
13C,15N-labeled sample at pH 6.5 without buffer or salt.
The HSQC spectrum is well dispersed with peaks of
comparable line width, which is characteristic for a well-
folded monomeric protein (Fig. 5). The HSQC showed
46 distinct amide peaks, which presumably originate from
peptide bonds, as compared to a theoretical maximum of
51 unique peptide peaks. This is indicative of only one
detectable species in the analyzed sample, which is in
accordance with data from our previous hydrogen (1H/2H)
exchange experiments. Resonance assignments for resi-
dues 3–47 were carried out by standard methods using a
set of triple resonance multidimensional NMR experi-
ments (Cavanagh et al. 1995). We did not observe any
resonances that could be attributed to the two N-terminal
residues and the C-terminal His tag. One peak in the
HSQC remained unidentified after this assignment. Com-
parison of HSQC spectra with different sweep widths
ruled out the possibility that it could be a folded side-
chain peak; thus, presumably it represents one of the
unassigned terminal residues. The assignment of the non-
labile side-chain resonances for residues 3–47 is nearly
complete as only Hb of Thr10 and Hz of Phe13 are lack-
ing. The chemical shift of HN of Cys5 is unusually high
(11.3 ppm), as reported also for bacterial and plasma-
derived SMB (Kamikubo et al. 2004; Mayasundari et al.
2004).
Initially, our structure calculations were carried out
without any restraints originating from disulfide bonds.
We subsequently introduced constraints corresponding to
each of the disulfide configurations shown in Figure 1.
During the initial calculations in CYANA, the SMB-2
disulfide configuration produced fewer violations and
better geometry. After water refinement, this preference
disappeared, and the statistics for the structure calcula-
tions with each of the three disulfide connectivities be-
came acceptable (Table 1). Since the hydrogen (1H/2H)
exchange data unambiguously demonstrates that the
solvent exposure of SMBPichia is replicated by only the
synthetic domain with the disulfide configuration SMB-2,
we proceeded using this disulfide connectivity.
The SMBPichia domain is folded into a roughly globular
structure with the disulfide bonds buried in the core
(Fig. 6). Although this domain primarily consists of loops
with no well-defined secondary structure, two very short
helical elements are nevertheless present (residues 24–
28 and 34–38). The ensemble of NMR structures we
obtained for SMBPichia is highly similar to the crystal
structure reported for SMB-2 (Zhou et al. 2003) and the
NMR structure for SMB-1 (Kamikubo et al. 2004) with
backbone heavy atom RMSDs for residues 3–39 of 1.18 Å
and 1.71 Å, respectively (Fig. 7, left panel). As opposed
to this, we were unable to satisfactorily superimpose our
structure on that published for SMB-3 (Mayasundari et al.
2004), as shown in Figure 7 (right panel). The PAI-1-
binding residues are found in a contiguous hydrophobic
patch on the surface of the domain, as reported previously
(Zhou et al. 2003). Interestingly, Gln29 has an unusual
Figure 5. The 15PN–1H HSQC spectrum of SMBPichia. This HSQC spectrum was recorded at pH 6.5 in 10% D2O at 25°C and
750 MHz. The peaks are well dispersed with similar intensities as is characteristic for a well-folded protein.
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geometry, with the backbone occupying a positive f angle.
This is confirmed by the presence of a strong NOE between
HN and Ha for this residue (Ludvigsen and Poulsen 1992).
This geometry allows the backbone to undergo a sharp turn
to accommodate the disulfide bridge Cys25–Cys31.
Discussion
The SMB domain has four disulfide bonds within only
35 residues and is highly resistant to digestion by all the
proteases we have tested, that is, trypsin, pepsin, Asn-N,
Glu-C, and thermolysin. The proximity of the disulfides
combined with the resilience toward proteolytic degrada-
tion render the assignment of the disulfide configuration
of SMB a methodological challenge. Three different
disulfide pairings have been published so far, using
SMB from different sources (Fig. 1), including SMBplasma
generated from vitronectin purified from human blood
(Horn et al. 2004). A linear set of disulfide bridges (SMB-
1) was reported for a recombinant product produced in
E. coli using partial reduction with subsequent alkylation
(Kamikubo et al. 2002). Another disulfide connectivity
(SMB-2) was derived from SMB produced in E. coli
based on electron densities recorded for SMBPAI-1
complexes by X-ray diffraction (Zhou et al. 2003). A
third connectivity (SMB-3) was finally reported for
plasma vitronectin-derived SMB, also relying on partial
reduction and alkylation (Horn et al. 2004).
Generation of free thiol groups by partial reduction
during experimental disulfide assignment calls for great
caution in the subsequent analysis, because of the obvious
risk of thiol–disulfide interchange. If used, such protocols
require corroboration by independent methods. The orig-
inally determined connectivity in SMB-1 was therefore
sought to be verified by introduction of a CNBr cleavage
site by site-directed mutagenesis (Kamikubo et al. 2004).
Despite being functionally active, this mutant (Asn14 !
Met) did not produce a fragmentation pattern compatible
with the original set of disulfide bonds (Kamikubo et al.
2004), leading us to question the validity of the disulfide
connectivities in SMB-1. This suspicion was further
substantiated by the impaired PAI-1 binding reported
for a synthetic SMB with the disulfide bonds of SMB-1
(Li et al. 2007). In accordance, we find that this synthetic
SMB-1 behaves as a misfolded domain without detect-
able PAI-1 binding in hydrogen (1H/2H) exchange experi-
ments. Similar properties were observed for the synthetic
SMB-3, demonstrating that neither SMB-1 nor SMB-3 is
compatible with proper folding and ligand binding. In
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Disulfide configuration SMB-1 SMB-2 SMB-3
RMSD relative to mean (3–39):
Backbone heavy atoms 0.48 Å 0.64 Å 0.45 Å
All atoms 1.20 Å 1.33 Å 1.16 Å
Average number of violations:
NOE: >0.3 Å 0.1 0.05 3.95
NOE: >0.5 Å 0 0 2.8
Dihedrals: >5° 3.1 1.95 5.5
Ramachandran values (3–39) (%):
Most favored regions 71.3 74.9 65
Additionally allowed regions 27.2 23.3 32.7
Generously allowed regions 1.0 1.7 2.1
Disallowed regions 0 0.1 0.1
Figure 6. Schematic representation of the NMR structure of human SMB
produced in P. pastoris. (Upper panel) The backbones of the 20 structures
with the lowest energy are shown in the cartoon representation for SMB
residues 3–47. Side chains of the PAI-1-binding residues (Phe13, Asp22,
Leu24, Tyr27, and Tyr28) are shown as sticks and are clustered in a
hydrophobic patch on the surface of the SMB domain. Multiple NOEs
demonstrate that these side chains interact. Nonetheless, the lack of
stereospecific assignments for the aromatic residues suggest that the rings
can flip in solution. (Lower panel) The disulfide bonds are found buried in
the core of the domain, where they replace a traditional hydrophobic core.
The disulfide configuration SMB-2 provides a high degree of cross-linking
between regions that are distant in the sequence, thus presumably lowering
the entropy of the unfolded state.
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contrast, synthetic SMB-2 exhibits an identical hydrogen
exchange protection (i.e., structure) as compared to
SMBplasma, SMBPichia, and SMBS2. This similarity is also
extended to PAI-1 binding. These data are consistent with
the observation by Li et al. that either SMB-1 or SMB-3
produces SMB domains with severely compromised
PAI-1 binding, whereas SMB-2 produces an SMB domain
with an affinity comparable to that of SMBplasma (Li et al.
2007). The lack of amide protection we observe in
(1H/2H) exchange experiments provides the structural
basis for this observation, as SMB-1 and SMB-3 fail to
yield a properly folded domain, thus disproving the
proposition that different sets of disulfide connectivities
can stabilize the same SMB fold (Kamikubo et al. 2004).
Together, these data therefore conclusively demonstrate that
only the disulfide connectivity of SMB-2 is compatible with
a folded and biologically active SMB domain. As PAI-1
binding was verified for all SMB preparations irrespective
of origin, that is, from E. coli (Kamikubo et al. 2002; Zhou
et al. 2003) and from plasma-derived vitronectin (Fig. 3),
they must contain the disulfide pattern represented by
SMB-2. The deviating connectivities represented by
SMB-1 and SMB-3 most likely stem from thiol–disulfide
interchange during partial reduction (Li et al. 2007).
The three-dimensional structure of the SMB domain is
also the subject of some controversy, which partly arises
because of the abovementioned ambiguity on the disul-
fide arrangements. The first structure was solved by X-ray
crystallography for E. coli produced SMB in complex
with PAI-1 (Zhou et al. 2003) defining the SMB-2
disulfide connectivity. Subsequently, the NMR structure
of free SMB produced by E. coli was solved using the
SMB-1 connectivity (Kamikubo et al. 2004). These two
structures present a comparable backbone fold of SMB
despite the fact that they encompass different sets of
disulfide bonds. Finally, the NMR structure of plasma-
derived SMB was reported using the SMB-3 connectivity
(Mayasundari et al. 2004). This structure is more loosely
defined and heterogeneous compared to the previous
structures and mainly agrees on the location of the short
a-helical stretch (residues 24–28).
In the present study, we have expressed and charac-
terized recombinant SMB produced in two eukaryotic
hosts. Prior to structure determination of the recombinant
SMBPichia domain, we verified that its overall structure
and dynamics are equal to those of SMBplasma by com-
parison of their hydrogen exchange kinetics. Our data
clearly show that the three forms are indistinguishable
in their global exchange kinetics (Fig. 2, lower right
panel). Furthermore, an identical change in the exchange
kinetics is introduced in all SMB preparations upon the
high-affinity binding to PAI-1 (Fig. 3, lower panel). On
average, nine backbone amides are shifted toward slow
exchange in the presence of PAI-1, which demonstrates
that the binding of the SMBPAI-1 complex is sufficiently
tight to exclude water from the interface. Apart from
demonstrating the structural similarity between the SMB
preparations, this analysis also establishes the biological
activity of both the recombinant and the plasma-derived
SMB. This experiment emphasizes that the SMBplasma is,
indeed, biologically active, eliminating this property as
an explanation for the difference in the solved structures,
Figure 7. Comparison of the different three-dimensional structures reported for SMB. (Left panel) Overlay of the backbone traces for
SMBPichia (residues 3–39) displayed in blue on the structures reported for SMB-1 (red) and SMB-2 (green); (right panel) the overlay on
SMB-3 (aquamarine). The structures were fitted in MOLMOL using residues 3–39 for SMB-1 and SMB-2, but only using residues 19–
39 for SMB-3. As evident from this comparison, the structure of SMBPichia resembles those reported for SMB-1 and SMB-2, whereas it
fails to converge on the structure reported for SMB-3. The PDB coordinates used were: 1SSU for SMB-1 (Kamikubo et al. 2004),
1OC0 for SMB-2 (Zhou et al. 2003), and 1S4G for SMB-3 (Mayasundari et al. 2004).
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as proposed previously (Kamikubo et al. 2006). Since the
isotope exchange experiment is sensitive to conforma-
tional heterogeneity in the SMB preparation, subpopula-
tions would produce bimodal exchange patterns in the
isotope envelopes. Importantly, the mass distribution of
the recombinant SMBPichia is shifted as a single isotope
envelope both in the presence and absence of PAI-1. This
demonstrates that the preparation is homogeneous and
that the entire population is binding active. As alluded to
above, the hydrogen (1H/2H) exchange kinetics recorded
for SMBPichia alone or in complex with PAI-1 are com-
patible only with the SMB-2 disulfide connectivity.
Having verified that the SMB expressed in Pichia is
biologically active and in a conformation identical to the
SMBplasma, we have set the stage for the structure deter-
mination of SMBPichia by NMR spectroscopy. The models
calculated from the NMR data reveal a well-folded
structure of the core region of the SMB domain that is
cross-linked by disulfide bonds. A classic hydrophobic
core is absent in the SMB domain, as it contains very few
hydrophobic residues. Multiple crossed disulfide bonds
may, nevertheless, provide such small domains with
sufficient structural stability, alleviating the necessity of
a hydrophobic core. The majority of the hydrophobic
residues in the free SMB domain are found in a surface-
exposed patch (Fig. 6) that is involved in ligand binding,
as demonstrated for PAI-1 binding by X-ray crystallog-
raphy (Zhou et al. 2003) and for uPAR by alanine-
scanning mutagenesis. We detected multiple NOEs
between Phe13, Val15, Leu24, Tyr27, and Tyr28, suggesting
that these surface-exposed hydrophobic residues interact
to reduce their contact with water.
The present NMR structure for free SMBPichia is very
similar to the structures described previously for E. coli
produced SMB by X-ray crystallography (Zhou et al.
2003) or NMR (Kamikubo et al. 2004), despite the fact
that the latter assumed a disulfide connectivity now
known to produce a nonfunctional, misfolded domain.
Notably, the structure published for SMBplasma differs
markedly from the present structure of SMBPichia. This
discrepancy is unexpected since our hydrogen (1H/2H)
exchange experiments cannot distinguish between the
solvent exposures of the two SMB preparations. It should,
however, be emphasized that the structure solved for
SMBplasma relied on data recorded on a very dilute (0.09
mM), unlabeled protein sample, owing to the inherent
difficulty in preparing large amounts of SMB from
vitronectin purified from plasma. This compromise
resulted in rather few long-range NOE effects, which
constitute the pivotal data for subsequent structure cal-
culation (Mayasundari et al. 2004). In the absence of suffi-
cient numbers of such long-range NOEs, assumed disulfide
restraints are expected to have a disproportionately large
and undesirable impact on structure calculations.
To provide an explanation for the apparent ambiguity
between structure and disulfide connectivity for E. coli
produced SMB, it was previously proposed that a func-
tional and folded SMB domain could be achieved with
different sets of disulfide bridges (Kamikubo et al. 2004).
A similar proposition was advanced in a recent bioinfor-
matics study on disulfide-rich protein domains based
solely on the different structures and disulfide connectiv-
ities reported for SMB (Cheek et al. 2006). This proposal
was apparently corroborated by molecular dynamics
simulations revealing that the SMB structure solved by
NMR has comparable conformational energies whether
using the disulfide connectivities of SMB-1 or SMB-2
(Kamikubo et al. 2004). These speculations were even
further advanced by the proposition that this alleged
ability of SMB to accommodate more than one set of
disulfide-bond connectivities could be functionally
important for the regulation of the multiple functions of
vitronectin (Chen and Hogg 2006). Our structure calcu-
lations produce a similar backbone fold irrespective of the
disulfide connectivity used, without significant violations
of the NMR data and the geometric properties imposed by
the force field. This indicates that the fold of the SMB
domain is theoretically capable of accommodating all
three published disulfide connectivities without steric
clashes. Nevertheless, the hydrogen (1H/2H) exchange
experiments unambiguously demonstrate that SMB
domains with disulfide connectivities corresponding to
SMB-1 and SMB-3 are misfolded and inactive. Intrigu-
ingly, this highlights that only one of the three connec-
tivities is capable of stabilizing the structure in its active
conformation despite the fact that all three connectivities
can be accommodated in the SMB fold. It is noteworthy
that the preferred disulfide connectivity (SMB-2) pro-
vides the highest degree of cross-linking between the
termini of the SMB domain, thus limiting the conforma-
tional freedom of these regions. This is in accordance
with the proposition that multiple disulfide bonds may
substitute the traditional hydrophobic core to introduce
the required stability of small domains, presumably by
lowering the entropy of the unfolded state (Thornton 1981).
In conclusion, we have solved the structure of the SMB
domain of vitronectin produced in P. pastoris. This recombi-
nant domain is ideally suited for further interaction studies as
revealed for PAI-1 binding by hydrogen (1H/2H) exchange
(present study) and for uPAR binding by surface plasmon
resonance studies (Gårdsvoll and Ploug 2007).
Materials and Methods
Materials and protein preparations
Deuterium oxide (99.9 atom % D) was obtained from Cam-
bridge Isotope Laboratories. Ultra-high quality water was
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obtained from a PURELAB Ultra unit (ELGA Labwater).
Deuterated PBS buffer (pH 7.7, uncorrected value) was prepared
from PBS buffer by two cycles of lyophilization and redis-
solution in D2O.
Purified SMB (1–51), derived from plasma vitronectin by
CNBr cleavage, was generated as described (Mayasundari et al.
2004) and denoted SMBplasma. Purified SMB preparations with
three different, predefined disulfide connectivities (SMB-1,
SMB-2, and SMB-3) (Fig. 1), controlled by Acm-protection of
selected cysteines during peptide synthesis, were kind gifts from
Dr. W. Lu (Li et al. 2007). Recombinant enterokinase (EC
3.4.21.9) was from Stratagene. Recombinant active PAI-1 was
produced in E. coli and was a kind gift from Dr. M.D. Andersen
(Novo Nordisk, Bagsværd, Denmark). The penta anti-His
monoclonal antibody was purchased from Invitrogen.
Expression of SMB in Drosophila S2 cells
Recombinant SMB constructs covering residues 1–44 (SMB1–44,
SMB-D22R1–44) and 1–47 (SMB1–47) of human vitronectin were
expressed and purified as fusion proteins with the domain III
of uPAR as C-terminal purification tag in Drosophila S2 cells
using the Drosophila expression system (Invitrogen) as
described in detail elsewhere (Gårdsvoll et al. 2007).
Expression and isotope labeling in P. pastoris
To enable subsequent biosynthetic 15N and/or 13C labeling, re-
combinant SMB1–47 with a C-terminal 6-histidine tag (SMBPichia)
was produced using a P. pastoris expression system (Invitrogen).
The plasmid HSP-pUC18 with cDNA encoding human vitronectin
was obtained from American Type Culture Collection, no. 65450.
Two synthetic oligonucleotide primers were used for PCR
amplification of the DNA fragment encoding residues 1–47 from
vitronectin, together with a C-terminal His-tag, a stop codon, and
appropriate restriction sites in bold: 59-CGCCTCGAGAAAA
GAGACCAAGAGTCATGCAAGGGCCGCTGCAC-39 and 59-
TAGTCTAGATTAATGATGATGATGATGATGGTCCCCGCGA
GTCACTTGGGGCTTGC-ACTC-39. Subsequently, the ampli-
fied DNA was cloned into the vector pPICZa A. The resulting
construct pPICZa A SMB1–47-His thus encodes the secretion
signal of the a-mating factor from Saccharomyces cerevisiae
fused to His6-tagged SMB
1–47, under the control of the alcohol
oxidase 1 promoter. A single Kex2 signal cleavage site is con-
tained within the C-terminal end of the a-factor sequence, which
ensures a recombinant product with a free native N terminus of
vitronectin.
Electro-competent cells of P. pastoris strain X-33 were
transfected with 10 mg of PmeI-linearized vector by electro-
poration, plated on YPDS agar containing Zeocin (100 mg/mL),
and incubated for 5 d at 30°C. Sixty Zeocin-resistant colonies
were then selected and screened for expression in BMMY using
daily additions of 0.5% (v/v) methanol. Expression levels were
monitored by SDS-PAGE followed by silver staining or immu-
noblotting using an anti-His monoclonal antibody. The most
strongly expressing clone was selected for large-scale produc-
tion in BMMY. Owing to an extraordinary protease resistance
of the recombinant SMB, we used an unusually long induction
period of up to 10 d for production in Pichia.
For 15N and 13C labeling, the abovementioned Pichia clone
was expanded by growth in 2% (w/v) 13C glucose and 1.2%
(w/v) (15NH4)2SO4. The yeast was pelleted by centrifugation
(5000g), resuspended in a medium containing 1.2% (w/v)
(15NH4)2SO4 and supplemented daily with 1% (v/v) (
13C)
methanol for 5 d while grown at 30°C during orbital shaking at
300 rpm.
SMBPichia was purified by Ni2+ NTA affinity chromatography
followed by reversed-phase chromatography on a VYDAC C4
column using a 50-min linear gradient from 0% to 70% (v/v)
acetonitrile in 0.1% (v/v) TFA. This protocol led to a purified
SMBPichia with an average isotope incorporation close to 100%
for the doubly labeled product as judged by matrix-assisted
laser desorption ionisation time-of-flight mass spectrometry,
MALDI-TOF MS (average mass 6481.3 Da). The yield of
purified SMB was 3–4 mg/L when Pichia was cultured on
minimal medium.
Global amide hydrogen (1H/ 2H) exchange analysis
of SMBS2, SMBPichia, and SMBplasma monitored
by mass spectrometry
Prior to the isotopic exchange experiment, a solution containing
SMBS2, SMBPichia, and SMBplasma was prepared, in which their
concentrations were adjusted to yield similar relative ion abun-
dances when analyzed concomitantly by electrospray ionization
mass spectrometry. The concentrations were 20 mM SMBS2,
30 mM SMBPichia, and 60 mM SMBplasma. This difference
reflects the distinct ionization efficiencies of the three SMB
variants. Isotope exchange was initiated by a 50-fold dilution of
the SMB mixtures into deuterated PBS at 25°C or 4°C. For time-
course experiments, 75-mL aliquots were withdrawn after 1 min,
5 min, 15 min, and 50 min of deuterium exchange, and fur-
ther isotope exchange was quenched by addition of 3 mL of
2.5% (v/v) TFA followed by snap freezing in liquid nitrogen.
Fully deuterated SMB (100% 2H control) was prepared by
60 min of incubation in deuterated solvents at 25°C and
15 min at 55°C. Complex formation with PAI-1 was achieved
by adding a ninefold molar excess of PAI-1 to one aliquot of the
SMB mixture and incubating for 1 h at 25°C prior to isotope
exchange. Protein concentrations were determined by amino
acid analysis (Biochrom 30 amino acid analyzer). Pairwise
comparison of recombinant SMBPichia and the three synthetic
SMB products with predefined disulfide connectivities were
performed in a similar manner.
Rapid desalting of SMB was performed with the liquid-
chromatography system described previously (Jørgensen et al.
2004). Solvents were delivered by two HPLC syringe pumps,
one for desalting and one for elution directly into the electro-
spray ion source of the mass spectrometer. Samples were
manually thawed and injected with an ice-cold glass syringe
into a stainless steel loop mounted on an injection valve. By
switching the position of this valve, the sample was flushed
from the loop to another valve equipped with a reversed-phase
C18 microcolumn (Rist et al. 2005) and was desalted at a
400 mL/min flow of 0.05% (v/v) TFA for 1 min. A step gradient
was used to separate the SMB variants from PAI-1, as the mass
spectrometric peaks from PAI-1 interfered with those of the
SMB variants. Elution of the SMB variants was achieved with
21% (v/v) acetonitrile (30 mL/min), 0.05% (v/v) TFA, and PAI-1
with 56% (v/v) acetonitrile. The total time from injection to
mass spectrometric detection was 2 min for SMB and 6 min for
PAI-1. The solvents, valves, and C18 microcolumn were main-
tained at 0°C in an ice-water bath. The liquid-chromatography
system was coupled to an electrospray ionization quadrupole
time-of-flight mass spectrometer (QToF Ultima, Micromass).
The capillary voltage was set to 3.5 kV, the cone voltage to 55 V,
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the RF lens 1 voltage to 70 V, and the ion source block tem-
perature to 80°C with a desolvation gas flow of 400 L/h at 200°C
and a nebulizing gas flow of 20 L/h at room temperature. The
deuterium content was determined by the average mass differ-
ence between the nondeuterated protein and the partly deuter-
ated protein. The residual proton content after isotope exchange
was attained using the average mass difference between the
partly deuterated protein and the 100% 2H control. Average
masses were calculated by two independent methods. In the
first, average mass shifts were determined from deconvoluted
mass spectra generated by the maximum entropy algorithm
(MaxEnt 1) provided with the Masslynx software. In the second,
the deuterium contents were determined using the HXexpress
software (Weis et al. 2006). Nearly identical results were
achieved by either method, and the data shown were obtained
with HXexpress.
NMR spectroscopy
The protein concentration of the doubly labeled preparation was
measured by absorbance at 280 nm prior to lyophilization using
an extinction coefficient of 4470 M1 cm1. The NMR sample
contained ;0.4 mM 13C,15N-labeled SMB adjusted to pH 6.5 in
10% (v/v) D2O and 3 mM NaN3. All spectra were recorded at
298°K on a Varian Unity Inova 750 MHz NMR spectrometer
equipped with a cold probe and Z-field gradient. The spectra
were processed in nmrDraw (Delaglio et al. 1995) and analyzed
in Pronto3D (Kjær et al. 1994) or Sparky (Goddard and
Kneller). The backbone assignments were obtained for residues
3–47 by a standard procedure (Cavanagh et al. 1995) using
HSQC, HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB,
and CBCA(CO)NH spectra (all pulse sequences were from the
Varian Protein Pack version 1.6c). Side-chain assignments were
obtained using N-edited TOCSY-HSQC and HCCH-TOCSY
spectra. The chemical shifts have been deposited in BMRB
(acc. code 15271). NOE restraints were generated from 2D
NOESY, N-edited NOESY-HSQC, and C-edited NOESY-HSQC
with mixing times of 150 ms. NOESY peaks of at least twice the
noise were picked by visual inspection and compiled into NOE
peak lists for subsequent structure calculation. Twenty-one pairs
of f and u angle intervals were generated using TALOS
(Cornilescu et al. 1999) from the list of chemical shifts and
added as restraints in the structure calculations. Automated
NOE assignment and initial structure calculations were carried
out using the noeassign module of CYANA 2.21 (Güntert et al.
1997; Herrmann et al. 2002) with a maximal upper NOE
distance set at 6.5 Å and calibrated using a median NOE length
of 4.5 Å. In each of the seven rounds of iterative NOE
assignment and structure calculation, 100 structures were
calculated during 10,000 steps of torsion angle dynamics. Prior
to the NOE assignments, the methyl and aromatic regions were
interactively assigned, and these were kept fixed during the
automatic assignments. No restraints representing the disulfide
bonds were introduced, to avoid bias toward a specific disulfide
pairing. In the last four calculations, the initial distance assign-
ments were allowed an elasticity of 50% within the fixed upper
limit. The C-terminal His6-tag was excluded from the structure
calculations, since no resonances were attributed to this part of
the molecule. Several undefined resonances were introduced
into the automatic NOE assignments as free-floating proxy
atoms (Ab et al. 2006). This led to assignment of the e-proton
of Arg8, the d-protons of Asn14, and the g-proton of Gln20 by
inspection of the NOEs of the proxy atoms, and these assign-
ments were used in subsequent calculations. The CYANA
calculations resulted in a set of structures with RMSD <3 Å in
the first round, and the overall structure did not change in
subsequent rounds in compliance with the quality criteria
recommended (Herrmann et al. 2002). Subsequently, restraints
representing the three different disulfide configurations pub-
lished previously were introduced in three different steps of
calculations, and 100 structures were calculated during 5000
steps of torsion angle dynamics in CYANA. The 20 best
structures in terms of number of violations were transferred to
CNS (Brunger et al. 1998) using FormatConverter (Vranken
et al. 2005). In CNS, a brief restrained molecular dynamics run
was performed in a thin layer of explicit solvent in order to
improve the geometry of the models as described (Linge et al.
2003). The structures were analyzed using Procheck-NMR
(Laskowski et al. 1996). The statistics for the water-refined
structures can be seen in Table 1. The 20 structures with the
lowest energy and the Cys5–Cys21, Cys9–Cys39, Cys19–Cys32,
Cys25–Cys31 disulfide configuration (SMB-2 in Fig. 1) were
selected and submitted to the PDB (acc. code: 2jq8).
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